https://www.selleckchem.com/products/nvl-655.html
20% NPWT 26.70% p=0.02). Secondary endpoints included number of major amputations (none in either group) and number of infections (NPWT+ 3.44% of patients, NPWT 6.66% of patients; p=0.57). Our initial findings show that this treatment significantly reduced wound closure times and accelerated healing in DFUs. It also demonstrated promising improvements in healing rates, with no significant increase in wound complications. Our initial findings show that this treatment significantly reduced wound closure times and accelerated healing in DF
Like
Comment
Share
